REGENACHE

What REGENACHE does

REGENACHE operates a regenerative medicine clinic under the ACHE Institute for Regenerative Medicine and Rehabilitation, founded in April 2016 by Dr. Mauricio Garcia Jacques in Spring (Houston metro), Texas. The practice delivers non-surgical orthopedic treatments using autologous orthobiologics — including bone marrow-derived mesenchymal stem cell concentrate therapy (Regenexx®), platelet-rich plasma (PRP), FDA-listed StemWave® acoustic wave therapy, and FDA-cleared Summus® Class IV laser therapy — to patients seeking alternatives to orthopedic surgery. Treatments cover elbow, foot/ankle, hand/wrist, hip, knee, and spine conditions, including arthritis, tendon and ligament tears, cartilage damage, and degenerative joint disease. The clinic operates two physical locations (Spring/Houston and West Lake Hills/Austin) supplemented by telemedicine consultations, with bilingual intake forms and a locally focused marketing approach built on educational content, patient testimonials, and Google Maps SEO.

The technical core is an on-site orthobiologics lab that uses Regenexx's proprietary processing techniques to generate over 25 different blood-based product variants at concentrations ranging from 2X to 20X, materially exceeding the cell concentrations achievable with bedside centrifuges used by most competitors. All injections are delivered under image guidance (ultrasound or fluoroscopy) with accuracy within 1 millimeter. The practice is a certified Regenexx provider and benefits from the network's research and registry infrastructure — including the largest orthopedic stem cell registry in the world tracking close to 10,000 patients and over 50% of the world's published orthopedic stem cell literature. Two proprietary supplements (Advanced Stem Cell Support Formula and Turmeric Curcumin Complex) are sold only for in-clinic pickup.

The business model is direct-to-consumer and primarily cash-pay. Insurance typically covers initial evaluation, diagnostic testing, and some follow-up services, but most insurance plans do not cover Regenexx procedures, StemWave, or Summus laser therapy, making the bulk of procedure revenue out-of-pocket, although HSA/FSA funds are eligible. Patients are acquired through the company website, educational blog content, patient testimonials, local SEO, phone/email contact, and physician referrals. REGENACHE is privately held, founder-controlled, with no disclosed external investors, and operates as part of ACHE Medical Group alongside ACHE Institute and iACHE.

Name

REGENACHE

Legal name

REGENACHE

Website

https://regenache.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

REGENACHE operates a two-location Texas regenerative medicine clinic (Spring/Houston and Austin/West Lake Hills) offering non-surgical orthopedic treatments — including Regenexx bone marrow concentrate therapy, PRP, StemWave, and Summus laser — to individual patients seeking cash-pay alternatives to orthopedic surgery.

Ownership category

akta.pro rank

Product category

Regenerative Medicine / Orthopedic Services

SIC

Services-Health Services (8000)

akta.pro primary industry

Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)

Keywords

• Regenerative medicine
• Non-surgical orthopedics
• Platelet-rich plasma
• Bone marrow concentrate
• Orthobiologic injections

Headquarters

HQ city

Spring

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Regenerative Medicine Procedures: Revenue from Regenexx procedures (bone marrow concentrate and PRP injections) for orthopedic conditions. These are the primary revenue generators for the clinic. Insurance typically covers evaluation and diagnostic testing, but most insurance plans do not cover Regenexx procedures, making them largely out-of-pocket for patients.
2. StemWave Therapy: Non-invasive acoustic wave therapy sessions for musculoskeletal pain and inflammation. Revenue from treatment sessions, either as standalone service or bundled with regenerative procedures.
3. Summus Laser Therapy: FDA-cleared Class IV laser therapy treatments. Revenue from laser treatment sessions, which can be experienced as standalone service or alongside other therapies.
4. Supplements: Sale of Advanced Stem Cell Support Formula and Turmeric Curcumin Complex supplements. Available for pickup at clinic locations only (no shipping). These are complementary products recommended before and after stem cell procedures.
5. Consultations and Follow-up Care: Revenue from consultations, physical examinations, follow-ups, durable medical equipment, bracing, medication, and physical therapy referrals. These are typically covered by insurance.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

REGENACHE is a regenerative medicine clinic (operating as ACHE Institute for Regenerative Medicine and Rehabilitation) that delivers non-surgical orthopedic treatments. Core services include Regenexx Procedures (bone marrow concentrate therapy and platelet-rich plasma), StemWave acoustic wave therapy, and Summus Medical Laser Class IV laser therapy, complemented by Advanced Stem Cell Support Formula and Turmeric Curcumin Complex supplements.

Product overview

REGENACHE is a regenerative medicine clinic offering a suite of non-surgical orthopedic treatments. The core offerings include Regenexx® Procedures (bone marrow concentrate therapy and platelet-rich plasma injections), StemWave® acoustic wave therapy, and Summus® Medical Laser therapy. These are complemented by proprietary dietary supplements (Advanced Stem Cell Support Formula and Turmeric Curcumin Complex). The clinic operates as ACHE Institute for Regenerative Medicine and Rehabilitation, providing treatments for conditions affecting the elbow, foot/ankle, hand/wrist, hip, knee, and spine.

Differentiator

Problem solved

Functional benefit

Brands

• Regenexx Procedures: Non-surgical injection treatments using bone marrow concentrate therapy and blood platelet treatments for orthopedic injuries
• StemWave Therapy
• Summus Medical Laser
• Advanced Stem Cell Support Formula
• Turmeric Curcumin Complex

Products and services

• Regenexx Procedures

Quantifiable outcome

• Patients rated 'good' candidacy have ~75% odds of deriving ~75% improvement from the procedure. 'Good to fair' candidacy yields ~65-70% odds of ~65-70% improvement.
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Regenexx: Corporate parent network of which REGENACHE is a licensed affiliate; Regenexx pioneered orthopedic bone marrow concentrate procedures and provides the IP, lab protocols, training, and research registry that REGENACHE's offering depends on, making it the most directly comparable entity.
• NSI Stem Cell: Multi-location US stem cell and regenerative therapy clinic network offering PRP and stem cell treatments for orthopedic and other conditions; comparable cash-pay regenerative medicine business model targeting similar patients.
• Centeno-Schultz Clinic: Founding Regenexx clinic in Boulder, Colorado led by the physicians who pioneered orthopedic bone marrow concentrate and PRP procedures; operates the same Regenexx protocols, image-guided injection techniques, and lab-processing platform as REGENACHE.
• The Orthohealing Center: Los Angeles-based orthopedic regenerative medicine practice offering PRP, bone marrow concentrate, and other orthobiologics with image-guided injection techniques; directly comparable independent clinic in the same niche as REGENACHE.
• Celltex Therapeutics: Houston-based regenerative medicine company focused on autologous mesenchymal stem cell therapy for orthopedic and other indications; geographically adjacent and operates in the same orthobiologics niche as REGENACHE.

Broad incumbents

• Hospital for Special Surgery (HSS): Largest US specialty hospital focused on orthopedic and rheumatologic care, including sports medicine and joint replacement; represents the established surgical alternative that regenerative medicine clinics like REGENACHE position against.
• Cleveland Clinic Orthopaedic & Rheumatologic Institute: Major academic orthopedic center where REGENACHE's founder trained; offers a full orthopedic service line including surgical interventions and serves as the broad incumbent that patients may choose over regenerative alternatives, shaping the competitive context REGENACHE operates in.

Emerging players

• Summus Medical Laser (Corporate): Provider of the Class IV Summus laser technology that REGENACHE uses in clinic; relevant as both a technology supplier and as an emerging distribution network of clinics offering similar laser-based pain relief therapies.

Market position

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/regenache

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about REGENACHE